| Trial ID: | L2313 |
| Source ID: | NCT00612625
|
| Associated Drug: |
Glucagon-Like Peptide-1
|
| Title: |
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: glucagon-like peptide-1|DRUG: Saline
|
| Outcome Measures: |
Primary: insulin secretion rate (ISR) were derived by deconvolution of c-peptide. ISR is expressed as pmol/kg/min, 180 minutes | Secondary: The calculated ISR values was plotted against the ambient plasma glucose. The slopes of this linear relationships were calculated by cross-correlation analysis and is and estimation of beta-cell responsiveness (pmol/kg/min)/mmol/l, 180 minutes
|
| Sponsor/Collaborators: |
Sponsor: Hvidovre University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
9
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2004-02
|
| Completion Date: |
2004-12
|
| Results First Posted: |
|
| Last Update Posted: |
2008-02-12
|
| Locations: |
Dept. of Endocrinology, Hvidovre Hospital, Copenhagen, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT00612625
|
